Dr. Marcus E. McKenzie, MD

Dr. McKenzie practices at Baylor Scott & White Medical Center - Plano in Plano, Texas, part of Baylor Scott & White Health.

Dr. McKenzie's NPI, 1588640213, was assigned on December 15, 2005. Dr. McKenzie graduated from UTMB Health in 1998. Dr. McKenzie holds Texas license M4342.

Dr. McKenzie's primary practice is Baylor Scott & White Medical Center - Plano, at 4700 Alliance Boulevard, Plano, TX 75093 in Collin County. The practice phone is (469) 814-2000.

Dr. McKenzie's primary practice is Baylor Scott & White Medical Center - Plano in Plano, Texas, part of Baylor Scott & White Health. Dr. McKenzie is also affiliated with Baylor Scott & White The Heart Hospital - Plano. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. McKenzie to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKenzie practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. McKenzie's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. McKenzie is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. McKenzie's licenses on file in 3 states: Texas, District of Columbia and Maryland.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. McKenzie treats.

CMS data shows 6,374 Medicare services from Dr. McKenzie across 38 procedure codes in 2024, for 2,286 Medicare patients. Medicare paid $388,014 for them.

CMS counts 2,286 Medicare patients who saw Dr. McKenzie in 2024. The largest group is 75 to 84, with 1,054 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McKenzie's median patient age at 71, with 42% women.

In 2024, Dr. McKenzie wrote 6,386 Medicare Part D claims for 807 patients. 86% of them were for generic drugs. CMS names the drug for 6,104 of them, across 69 drugs with 11 or more claims each, at $990,672 in total drug cost. In 2023, CMS named 5,350 claims across 61 drugs.

Dr. McKenzie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKenzie as offering telehealth.

Dmand AI links 14 papers to Dr. McKenzie in 2011. 2011 was the busiest year, with 2. The most frequent topics are Platelet Glycoprotein GPIIb-IIIa Complex, Coronary Disease and Platelet Aggregation. Dr. McKenzie has published most often in Cardiology. Dr. McKenzie's most frequent co-authors are Benjamin R. Oshrine, MD, Michael D. Greenberg, MD and Julio A. Panza, MD.

Dmand AI links Dr. McKenzie to 1 clinical trial. Conditions studied include Pulmonary Embolism and Embolism.

CMS Open Payments shows 525 general payments to Dr. McKenzie from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,249.

Dmand AI lists 1 award for Dr. McKenzie, most recently CMS Stage 1 2012 in 2011.

Dr. McKenzie graduated from UTMB Health in 1998. Dr. McKenzie is a member of ACC.

Dr. McKenzie is in network with 21 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.